[Update on leukoreduction therapies as alternatives for the treatment of severe pertussis]

Pedro Taffarel1, Facundo Jorro Barón1, Germán Bonetto2

  • 1Servicio de Terapia Intensiva, Hospital General de Niños Pedro de Elizalde, Ciudad Autónoma de Buenos Aires, Buenos Aires.

Insights

Severe pertussis in infants can be lethal due to pulmonary hypertension. Leukodepletion is a proposed treatment, but current evidence for its effectiveness in pertussis remains limited.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Pertussis (whooping cough) is a severe bacterial infection, particularly dangerous for infants under one year old.
  • Complications include hypoxemia, refractory pulmonary hypertension, and cardiovascular collapse.
  • Pathophysiology involves bacterial toxins, altered vascular tone, hyperviscosity, and thrombosis due to hyperleukocytosis.

Purpose of the Study:

  • To review the existing literature on leukodepletion as a treatment for severe pertussis.
  • To assess the efficacy and safety of leukodepletion in pediatric patients with severe pertussis.

Main Methods:

  • Systematic review of publications on leukodepletion in severe pertussis.
  • Analysis of patient data, cytoreduction procedures, and mortality rates from 18 identified studies.
  • Evaluation of study design limitations and overall evidence quality.

Main Results:

  • 18 publications reviewed, encompassing 288 patients and 68 cytoreduction procedures.
  • A mortality rate of 28% was observed in patients who underwent leukodepletion.
  • Published studies exhibit significant design limitations.

Conclusions:

  • Leukodepletion has been explored as a treatment for severe pertussis since 2004.
  • Despite its use, the evidence supporting leukodepletion in severe pertussis remains low due to study limitations.
  • Further high-quality research is needed to establish the role of leukodepletion in managing severe pertussis.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
883
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.3K
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
15.2K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K